Chemotherapy-Induced Peripheral Neuropathy and Changes in Cytoskeleton

Int J Mol Sci. 2019 May 9;20(9):2287. doi: 10.3390/ijms20092287.

Abstract

Despite the different antineoplastic mechanisms of action, peripheral neurotoxicity induced by all chemotherapy drugs (anti-tubulin agents, platinum compounds, proteasome inhibitors, thalidomide) is associated with neuron morphological changes ascribable to cytoskeleton modifications. The "dying back" degeneration of distal terminals (sensory nerves) of dorsal root ganglia sensory neurons, observed in animal models, in in vitro cultures and biopsies of patients is the most evident hallmark of the perturbation of the cytoskeleton. On the other hand, in highly polarized cells like neurons, the cytoskeleton carries out its role not only in axons but also has a fundamental role in dendrite plasticity and in the organization of soma. In the literature, there are many studies focused on the antineoplastic-induced alteration of microtubule organization (and consequently, fast axonal transport defects) while very few studies have investigated the effect of the different classes of drugs on microfilaments, intermediate filaments and associated proteins. Therefore, in this review, we will focus on: (1) Highlighting the fundamental role of the crosstalk among the three filamentous subsystems and (2) investigating pivotal cytoskeleton-associated proteins.

Keywords: chemotherapy-induced-peripheral-neuropathy; crosstalk; cytoskeleton; cytoskeleton-related proteins; dorsal root ganglia; microfilaments; microtubules; neurofilaments; neurotoxicity.

Publication types

  • Review

MeSH terms

  • Animals
  • Cytoskeleton / pathology*
  • Disease Models, Animal
  • Drug Therapy*
  • Humans
  • Intermediate Filaments / pathology
  • Neurons / pathology
  • Peripheral Nervous System Diseases / chemically induced*
  • Peripheral Nervous System Diseases / pathology*